 |
|
|
| |
Safety, Pharmacokinetics, and Degradation of Ultra-Long-Acting Injectable, Biodegradable, and Removable In-Situ Forming Implant with Cabotegravir for HIV Prevention
|
| |
| |
Presented at HIVR4P 2024, the 5th HIV Research for Prevention Conference
T. Le1, I. Young2, R. Shrivastava1, M.L. Cottre/13, C. Sykes3, A. Schauer 3, A.S. Kumbhar 4, R.S. Sellers 5, A.D. Kashuba3, C. Kozusek 4, S. R. Benhabbour*1,2
|
| |
|
|
|
|
|
